Tag: Cancer: Cervical

Rebounds seen in breast cancer and colonoscopy screening, while reported cervical cancer screening in 2023 remained below 2019 estimates

Review looks at data regarding barriers to and facilitators of breast and cervical cancer screening among people with disabilities

Cervical cancer incidence and mortality rate both higher among rural- versus urban-residing women

Among women aged 20 to 24 years who were screened for cervical cancer, rates decreased by 79, 80 percent for CIN2+, CIN3+

50 percent of patients with CIN3 had histopathological complete response; 63 percent had HPV16 clearance

Screening recommended every three years with cervical cytology for women aged 21 to 29 years, every five years with hrHPV screening at age 30 to 65 years

Estimated 26 additional cervical cancer deaths would have been expected between 2016 and 2021 assuming trends continued

Under most pessimistic scenario, one dose would avert fewer cervical cancer cases with difference of 3 percent over 100 years

Findings seen for women offered self-sampling kits for overdue cancer screenings

During same period, significant increase was seen in incidence of CIN3 among those aged 25 to 29 years